quinazolines has been researched along with cl 316243 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Collins, S; Cyr, M; Daniel, KW; Kumar, N; Medvedev, AV; Moukdar, F; Robidoux, J | 1 |
Fälting, JM; Holmström, TE; Mattsson, CL; Nedergaard, J; Wang, Y | 1 |
2 other study(ies) available for quinazolines and cl 316243
Article | Year |
---|---|
Maximal beta3-adrenergic regulation of lipolysis involves Src and epidermal growth factor receptor-dependent ERK1/2 activation.
Topics: 3T3-L1 Cells; Adipocytes; Adrenergic beta-3 Receptor Agonists; Animals; Cyclic AMP-Dependent Protein Kinases; Dioxoles; Enzyme Activation; ErbB Receptors; Estradiol; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Isoquinolines; Lipolysis; Mice; Quinazolines; Receptors, Adrenergic, beta-3; RNA, Small Interfering; src-Family Kinases; Sulfonamides; Tyrphostins | 2006 |
In brown adipocytes, adrenergically induced β₁-/β₃-(Gs)-, α₂-(Gi)- and α₁-(Gq)-signalling to Erk1/2 activation is not mediated via EGF receptor transactivation.
Topics: Adipocytes, Brown; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic Antagonists; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-3 Receptor Agonists; Animals; Clonidine; Dioxoles; Dose-Response Relationship, Drug; Drug Synergism; ErbB Receptors; Imidazoles; Male; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Norepinephrine; Phosphorylation; Quinazolines; Receptors, Adrenergic; Tyrphostins | 2013 |